KRAS and colorectal carcinoma: Conversely, our data indicate that inhibition of polyamine metabolism and EIF5A hypusination suppresses MYC protein levels, regardless to KRas mutational status, being the effect observed also in HT29 CRC cells, where KRas allele is not mutated23 (Supplementary Fig. 4b).